Kingstonist

Kingston-based team develops new tool to advance brain cancer research

A new Canadian-made tool, developed by a research team at Kingston Health Sciences Centre (KHSC) and Queen’s University, is ...

Arcutis Canada Announces Health Canada Approval of ZORYVE® Foam 0.3%, the First Steroid-Free Topical Foam for Scalp and Body Psoriasis, for Adults an…

Once-daily, steroid-free topical foam intentionally formulated to help manage psoriasis across difficult-to-treat areas of ...

Canadian tech, Calgary prof helped get Avalanche’s Landeskog back on the ice

“He was really struggling, and the main issue was he had made a couple of attempts at this point to get back on the ice and ...
Queen's University

3D-printed capsule gives researchers a clearer look at glioblastoma

KHSC and Queen’s neurosurgeon-scientists develop a low-cost tool to collect MRI-linked tumor samples for aggressive form of brain cancer.

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

ImmunoScape announced an in-licensing deal with Cue Biopharma to lead the development of a new class of therapies to attack solid tumor cancers.

Leap Therapeutics Rebrands as Cypherpunk; Expands Leadership Team to Drive New Zcash Treasury Strategy

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .